Study: Metformin Therapy May Reduce Risk of Colon Cancer in Diabetics

Researchers from the Shanghai Jiao Tong University in China have found that metformin treatment lowers the risk of colorectal cancer in patients with type two diabetes, according to a news release.

Advertisement

The researchers analyzed five studies from Jan. 1966-Mar. 2011, which consisted of 108,161 participants, to look for links between metformin and colon cancer incidence. The analysis revealed a 37 percent decrease in risk.

Related Articles about Colon Cancer:
Demographic Data Helps Determine Colon Cancer Risk
Bloodstream Infections Linked to Colorectal Cancer
Women Can Wait Longer Than Men to Start Colonoscopies, Study Finds

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Advertisement

Next Up in GI & Endoscopy

Advertisement

Comments are closed.